Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis
Clinical trial NCT06668493 · RECRUITING
Trial details
- NCT number
- NCT06668493
- Sponsor
- Ferring Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-12
- Primary completion
- 2029-11-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.